The Biomed Israel conference is set to attract some of the top senior officials in the healthcare industry. Among those attending are Richard Francis, CEO of Teva, Dr. Aharon (Roni) Gal, head of strategy and growth at Novartis, Prof. Yitzhak Kreis, director of Sheba Medical Center and many more. The conference promises to be a platform for networking and driving business opportunities as over 100 Israeli companies from various life sciences fields present their solutions and technologies.
The conference will cover all areas of life sciences including biopharma, medical devices, digital health, and diagnostic products. Attendees can expect lectures and discussions on the latest trends and breakthroughs in medicine such as women’s health, home hospitalization, AI in drug discovery, healthy aging and genetic medicine. Other topics to be discussed include brain health, cardiovascular diseases, digital biomarkers medical devices cancer treatments among others.
Ruthie Alon founder and CEO of Medstrada and co-chair of the conference emphasized the importance of showcasing Israel’s contributions to the global life sciences industry. Co-chair Dr. Ora Der highlighted Israel’s innovation in medical technologies by combining technology with biology chemistry medicine. The Innovation Authority has played a key role in supporting the industry’s growth providing funding for research start-ups infrastructure development.
The conference aims to explore new models for disease treatment healthcare costs conversion medical data into knowledge. Dr Nissim Darvish CEO Eliraz Ventures Fund acknowledged Innovation Authority support in driving success health technology sector Israel . This event will provide a platform for industry leaders discuss latest advancements collaborations field
+ There are no comments
Add yours